Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel)

Read more

PerkinElmer Expands Automated Mycotoxin Detection Kits Portfolio to Include All Major Mycotoxins

Read more

NICE recommends first treatment for rare blood disorder

Read more

Curia to Expand U.S. Commercial Manufacturing Capability

Read more

Sorrento Announces Its Lead Protein-Based COVID-19 Vaccine Candidate – DYAI-100 – Elicits Strong Neutralizing Immune Responses in Vaccinated Animals Against SARS-CoV-2 and Multiple Major Variants of Concern

Read more

Colgate-Palmolive signs on as Headline Partner for Microbiome Connect: USA

Read more

Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation

Read more

NRx Pharmaceuticals Announces Positive Safety Report for ZYESAMI (aviptadil) in NIH Sponsored ACTIV-3 Critical Care Study in Patients with Life-Threatening COVID-19

Read more

Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy

Read more

FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

Read more

Posts pagination

Previous Page 1 of 957 … Page 366 of 957 … Page 957 of 957 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version